Participated · Seed · Aug 2026

Solinide Photonics develops silicon nitride photonic integrated circuits and microcomb sources that can generate dozens of precise wavelengths from a single chip to enable higher-bandwidth, lower-power optical interconnects. The company targets AI data centres and telecommunications applications where moving large volumes of data between processors requires energy-efficient, high-capacity links. Solinide has demonstrated that its microcomb technology can meet the performance required for data-centre links and has integrated it into a rack-mounted product. As a spin-out from Chalmers University of Technology, the company is working toward commercial readiness, scalable manufacturing and real-world deployment. Current plans include expanding engineering and commercial teams, enhancing in-house prototyping and deepening partnerships with industry players. The recent €4 million seed raise is intended to fund these efforts and prepare the technology for manufacturing in Europe.

Participated · Equity · Aug 2026

Aligned Bio has developed a nanowire-based sensing platform designed to detect individual molecules with high sensitivity, with claims of read lengths of more than 1,000 bases using sequencing-by-synthesis reagents and up to 200x higher immunoassay sensitivity than conventional approaches. The technology originates from research at Lund University and Chalmers University of Technology and is designed for integration with industry-standard laboratory equipment and workflows. Founded in 2019 and headquartered in Lund, the company is transitioning from research to commercialization and plans to engage partners in the sequencing and proteomics industries. Recent financing of $3.6 million led by LMK will be used to scale nanowire consumable manufacturing and support commercial expansion. Pete Corish joined as CEO in June to lead commercialization efforts and partner discussions over the next six to twelve months. The company positions its platform as offering potential cost reductions and performance improvements for diagnostics, sequencing and proteomics applications.

Participated · Equity · Jul 2026

Xaga Surgical’s core product is a proprietary prostate biopsy device with a redesigned needle architecture that clinical studies indicate can reduce bacterial transmission by up to 96% and provide a more stable trajectory during tissue sampling. The company received FDA 510(k) clearance for the device and it is already being used by clinicians at institutions such as the Penn State College of Medicine. Xaga was founded by urologist Dr. Andreas Forsvall, who developed the technology based on clinical shortcomings he observed. Xaga reports that traditional biopsy needles contribute to complications in roughly 3% of procedures globally, and its device aims to lower those risks while improving diagnostic accuracy. The company recently raised 17 million SEK (≈€1.6M) to scale manufacturing and commercial operations in the U.S., prepare for CE marking in Europe, and pursue a broader portfolio of infection-prevention technologies for needle-based procedures.

Participated · Seed · Jul 2026

Rivus Batteries develops an organic variant of flow batteries designed for stationary, large-scale energy storage applications such as grid installations and datacenters. The company highlights that its chemistry avoids the use of critical metals. Founded and operating in Gothenburg, Rivus has spent three years developing its technology. With the new investment from Turbine Capital and Almi Invest Greentech, Rivus plans to optimize and scale up its manufacturing process. The company aims to commercialize the scaled manufacturing for deployment in large, fixed installations. The article does not disclose revenue, user metrics, prior funding amounts, or valuation.

Participated · Equity · Jul 2026

InfiniNode is a Chalmers University of Technology spin-out based in Gothenburg that develops licensable semiconductor IP for efficient on-chip data movement. Its technologies target interconnect and memory-subsystem challenges in RISC-V, multicore and chiplet-based System-on-Chip designs used in AI and high-performance computing. The company focuses on delivering scalable, low-latency and energy-efficient communication between processors, accelerators and memory to improve system performance and reduce SoC design complexity. With the newly secured €2 million in combined investment and grant funding, InfiniNode plans to expand its IP portfolio, deepen customer engagements and scale commercial operations. The article did not disclose revenue, user or other operating metrics.